There has been 200k of sales with just NZ alone. When the 9 hospitals have been on boarded in the UK and the UK is 10 times the NZ market, is it not unreasonable to see sales of circa $2 million per annum from just the UK market?
You then have other European markets and Middle East markets including Germany, Italy, Spain, Luxembourg , Switzerland, Belgium, Israel and Turkey.
Then there are the Asian markets of Hong Kong, Singapore and Malaysia and maybe more.
You then have the huge upside if approved, bile duct by the FDA.
Ann: Appendix 4E and Annual Report, page-11
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.001(9.09%) |
Mkt cap ! $45.40M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.3¢ | 1.2¢ | $303.5K | 25.08M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000000 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 9786329 | 8 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |